Revelation Biosciences | SC 13G/A:超過5%持股股東披露文件(修正)-Lind Global Fund II LP(2.9%),Lind Global Partners II LLC(2.9%)等
Revelation Biosciences | SC 13G:超過5%持股股東披露文件
Revelation Biosciences | 4:持股變動聲明-董事 TIDMARSH GEORGE F
Revelation Biosciences | 4:持股變動聲明-董事 TIDMARSH GEORGE F
Revelation Biosciences | 4:持股變動聲明-董事 TIDMARSH GEORGE F
Revelation Biosciences | 3:首次持股聲明-董事 Chawla Lakhmir S
Revelation Biosciences | 4:持股變動聲明-董事 TIDMARSH GEORGE F
Revelation Biosciences | 4:持股變動聲明-董事 TIDMARSH GEORGE F
Revelation Biosciences | 4:持股變動聲明-董事 TIDMARSH GEORGE F
Revelation Biosciences | 4:持股變動聲明-董事 TIDMARSH GEORGE F
Revelation Biosciences | 4:持股變動聲明-董事 ROPER JESS
Revelation Biosciences | 4:持股變動聲明-董事 LaBelle Curt H
Revelation Biosciences | 4:持股變動聲明-董事 CARVER JENNIFER
Revelation Biosciences | 4:持股變動聲明
Revelation Biosciences | 4:持股變動聲明
Revelation Biosciences | SC 13G:超過5%持股股東披露文件-Lind Global Fund II LP(5.2%),Lind Global Partners II LLC(5.2%)等
Revelation Biosciences | SC 13G:超過5%持股股東披露文件-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%)等
Revelation Biosciences | SC 13G:超過5%持股股東披露文件-AXA IM Prime Impact Master Fund I SCA SICAV-RAIF(8.32%),AXA IM Prime Impact GP S.à.r.l(8.32%)等
Revelation Biosciences | 5:權益變更年度報表
Revelation Biosciences | SC 13G/A:超過5%持股股東披露文件(修正)-ANDREW M. WEISS, PH.D.(0.00%)
暫無數據